glp 1 neurodegenerative disease Repurposing GLP1 agonists for diseases GLP-1R agonists protect against Alzheimer's
Description
Extremely nutrient-dense, providing both fiber and protein
Daily injected, Saxenda, a first-generation GLP-1, was the first drug approved for this
The problem is that "it's normal" and "it needs review" can feel identical from the inside
Companies must actively reshape ingrained perceptions that equate efficacy with injectables, while building confidence particularly among general practitioners who will be central to ensuring adoption on a broad scale
GLP1 acts through a Gproteincoupled receptor expressed on pancreatic beta cells and neurons of the central and peripheral nervous system (Kanoski et al., 2011
